What
This study examined the prevalence of latent tuberculosis infection (LTBI) among patients with diabetes mellitus (DM) in Taiwan and identified factors associated with LTBI risk in this population. Diabetes is recognized as an important risk factor for tuberculosis progression, yet evidence regarding LTBI burden among diabetic populations in Taiwan remained limited, particularly in the context of widespread Bacillus Calmette–GuĂ©rin (BCG) vaccination. Because routine childhood BCG vaccination and booster doses may reduce the accuracy of traditional tuberculin skin testing (TST), this study employed interferon-gamma release assay (IGRA) to provide a more reliable estimate of LTBI prevalence among diabetic patients.
Among 1,120 diabetic patients included in the analysis, 21.5% tested positive for LTBI, indicating a substantial burden of latent infection within this population. Patients with LTBI were significantly older, with a mean age of 58.2 years compared with 55.0 years in LTBI-negative individuals. Furthermore, the age of diabetes onset was also higher among LTBI-positive patients, suggesting that older individuals with diabetes may accumulate TB exposure risk over time. When stratified by age, patients older than 50 years demonstrated a markedly higher LTBI prevalence compared with those younger than 50 years (25.8% vs. 11.6%), highlighting age as a key risk determinant.
In contrast, glycemic control did not appear to influence LTBI prevalence. Neither average nor peak hemoglobin A1c levels over the preceding three years differed significantly between LTBI-positive and LTBI-negative groups. Similarly, diabetes treatment regimens—used as proxies for disease severity—showed no significant association with LTBI status. These findings suggest that while diabetes itself is associated with increased TB risk, the degree of glycemic control may not directly correlate with latent infection prevalence.
Other potential risk factors, including sex, body mass index, smoking status, and TB contact history, were not significantly associated with LTBI after analysis. However, age-stratified patterns showed male predominance across most age groups, particularly among LTBI-positive individuals. Overall, the study concluded that older diabetic patients, particularly those over 50 years, represent a high-risk population for LTBI and may benefit from targeted screening strategies using IGRA in TB-endemic settings.
How
This study used a cross-sectional design conducted at a regional hospital in northern Taiwan, specifically the Taipei Medical University–Shuang Ho Hospital. Participants included diabetic patients aged 20–70 years who attended a metabolic outpatient clinic between February 2011 and February 2013. Patients with active tuberculosis, suspected TB, HIV infection, autoimmune disease requiring immunomodulators, recent chemotherapy, liver cirrhosis, or hepatitis were excluded to minimize confounding factors that could influence LTBI detection or immune response.
Demographic and clinical information was collected from medical records and structured questionnaires. Variables included age, sex, smoking status, TB contact history, underlying comorbidities, and glycemic control indicators such as hemoglobin A1c. These variables were analyzed to identify potential risk factors associated with LTBI among diabetic patients. This comprehensive data collection enabled assessment of both clinical and behavioral determinants of latent TB infection.
LTBI screening was performed using the QuantiFERON-TB Gold In-Tube (QFT-GIT) assay, an interferon-gamma release assay considered more specific in BCG-vaccinated populations. Blood samples were analyzed using enzyme-linked immunosorbent assay (ELISA), and results were classified as positive or negative based on standard interferon-gamma thresholds. This laboratory-based approach allowed more accurate identification of latent infection compared with traditional skin testing in highly vaccinated populations.
Statistical analyses included comparisons between LTBI-positive and LTBI-negative groups, age-stratified analyses, and multivariate logistic regression to identify independent predictors of LTBI. The researchers further evaluated glycemic control, diabetes duration, and medication use as potential indicators of disease severity. Through this structured analytical approach, the study identified age—particularly over 50 years—as the most consistent predictor of LTBI among diabetic patients in Taiwan.
Source: Chang, A., Wu, C. Z., Lin, J. D., Lee, C. N., Tsai, K. Y., Wu, P. H., & Hsieh, A. T. (2022). Prevalence and risk factors for latent tuberculosis among diabetes patients in Taiwan: A cross-sectional study. The Journal of Infection in Developing Countries, 16(04), 644-649.